In contrast, the most prevalent genomic variations among individuals with metastatic iCCA were TP53 (23.5%), IDH1 (21.0%), ARID1A (17.6%), KRAS (15.1%), and PBRM1 (14.7%). This evidence concerns the gene PBRM1 and infantile convulsions and choreoathetosis.